Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older

Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
84 days
Participants
1640 (1381 completed)
Age Range
9-58 years
Efficacy
Intervention(s) Outcome
Acne
Sign in to read for free
Skin Oiliness
Sign in to read for free
Side Effects
Intervention(s) Outcome
Pain
Sign in to read for free
Peeling
Sign in to read for free
Skin Hydration
Sign in to read for free
Skin Redness
Sign in to read for free
Study Summary
Sign in to read for free